...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction.
【24h】

The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction.

机译:与替奈普酶相比,初次经皮冠状动脉介入治疗对急性心肌梗死中的髓过氧化物酶,妊娠相关血浆蛋白A,可溶性纤维蛋白和D-二聚体的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: Acute coronary reperfusion is accomplished pharmacologically with intravenous thrombolytic therapy or mechanically with primary percutaneous coronary intervention (PCI). METHODS: We have determined the immediate effects of the main coronary reperfusion procedures on the plasma concentrations of myeloperoxidase (MPO), pregnancy-associated plasma protein A (PAPP-A), fibrin monomer (FM) and D-dimer (DD). We studied a total of 38 patients admitted for ST-segment elevation infarct (STEMI). 18 patients were given thrombolytic therapy with tenecteplase and 20 were treated with primary PCI. RESULTS: The plasma concentrations of PAPP-A increased by a factor of six to eight times (p<0.001) following both reperfusion therapies. No significant increase was observed for MPO by either procedure. DD and FM concentrations both increased significantly following thrombolytic therapy, p=0.000, whereas only minor increases, although statistically significant for FM (p=0.013), were noted after PCI. DD and FM were highly correlated prior to the two treatment regimens (R=0.91), and were still highly correlated after PCI (R=0.94) and thrombolytic therapy (R=0.86). No correlation was demonstrated between PAPP-A and markers of activated coagulation. CONCLUSIONS: This is the first report of a significant rise in the plasma concentration of PAPP-A after PCI as compared to thrombolytic treatment (p=0.002) and may indicate a greater impact of PCI than that of thrombolytic therapy on target coronary plaques.
机译:简介:急性冠状动脉再灌注是通过药理学上通过静脉内溶栓治疗或机械上通过原发性经皮冠状动脉介入治疗(PCI)完成的。方法:我们确定了主要冠状动脉再灌注程序对髓过氧化物酶(MPO),妊娠相关血浆蛋白A(PAPP-A),纤维蛋白单体(FM)和D-二聚体(DD)血浆浓度的即时影响。我们研究了总共38例ST段抬高性梗死(STEMI)患者。 18例患者接受了替奈普酶溶栓治疗,20例接受了原发性PCI治疗。结果:两种再灌注疗法后,PAPP-A的血浆浓度增加了六到八倍(p <0.001)。两种方法均未观察到MPO显着增加。溶栓治疗后,DD和FM浓度均显着增加,p = 0.000,而在PCI后,尽管对FM具有统计学显着性(p = 0.013),但仅轻微增加。 DD和FM在两种治疗方案之前高度相关(R = 0.91),而在PCI(R = 0.94)和溶栓治疗后仍高度相关(R = 0.86)。在PAPP-A和活化凝血标记物之间未显示相关性。结论:这是第一个报告,与溶栓治疗相比,PCI后PAPP-A的血浆浓度显着升高(p = 0.002),可能表明PCI对溶栓治疗的靶标斑块的影响大于溶栓治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号